Form 4 Filing for 10x Genomics, Inc.

This filing details a series of stock sales by Shehnaaz Suliman, a director at 10x Genomics, Inc. The transactions occurred on September 22, 2026, and were executed under a Rule 10b5-1 trading plan. A total of 5623 shares of Class A Common Stock were sold at weighted average prices ranging from $78.1959 to $82.2768. The sales resulted in a decrease in post-transaction shares held by the reporting owner. The filing was signed by Randy Wu as Attorney-in-Fact for Shehnaaz Suliman on September 24, 2026. Specific details regarding the number of shares sold at each price point are available upon request, as per the footnotes. This is a standard disclosure for insider transactions.